Medistep Healthcare Ltd SME IPO 2025: 7 Powerful Insights for Smart Investors
Medistep Healthcare Ltd SME IPO 2025: 7 Powerful Insights for Smart Investors
Medistep Healthcare Ltd is gearing up for an exciting SME IPO in August 2025, offering investors a strategic opportunity in the pharmaceutical and healthcare sector. This detailed article covers everything about the Medistep Healthcare Ltd IPO including issue dates, price band, company financials, strengths, risks, and subscription status to help you make an informed investment decision.
Company Overview
Founded recently, Medistep Healthcare Ltd operates in the pharmaceutical and healthcare manufacturing industry with a focus on providing high-quality healthcare products. The company has shown remarkable revenue growth from ₹31.63 crore in March 2024 to ₹49.63 crore in March 2025, demonstrating strong market traction. The profit after tax (PAT) has also improved significantly by 42% year-on-year, supported by operational efficiencies and enhanced product portfolio. With experienced promoters and senior management spearheading operations, Medistep Healthcare is poised for growth in India’s burgeoning healthcare space.
IPO Details of Medistep Healthcare Ltd
- IPO Type: SME IPO
- Issue Size: Approximately ₹16.09 crore
- Price Band: Fixed price at ₹43 per share
- Lot Size: 1500 to 3000 shares (minimum investment around ₹64,500 to ₹1,29,000 depending on lot size)
- Open Date: August 8, 2025
- Close Date: August 12, 2025
- Listing Date: August 18, 2025 on NSE SME platform
- Grey Market Premium (GMP): Near zero or negligible, indicating fairly priced issue
IPO Objectives
The funds raised via this IPO will be primarily used for expansion of manufacturing facilities, enhancing marketing efforts, working capital requirements, and to strengthen the company’s overall financial position.
Pre-IPO Placements & Major Investors
Details of any pre-IPO placements or anchor investors for Medistep Healthcare Ltd have not been prominently disclosed, which is common in SME IPOs. Investors are advised to monitor disclosures during the IPO process.
Financial Highlights
- Revenue: ₹31.63 crore (FY 2023-24) to ₹49.63 crore (FY 2024-25)
- Profit After Tax (PAT): Increased 42% year-on-year
- Return on Equity (ROE): Data not widely available but improving profitability noted
- Net Worth & EPS: Significant growth reflecting stronger balance sheet and earnings
Peer Comparison
Comparing Medistep Healthcare Ltd with peers in pharmaceutical SME sector shows valuation focused on growth potential and niche healthcare markets. While exact PE and ROE ratios vary, Medistep’s strengthening revenue and profitability provide a positive outlook against competitors.
Strengths of Medistep Healthcare Ltd
- Experienced promoters and management team with deep sector knowledge
- Consistent revenue and profitability growth with strong client relationships
- High quality assurance and control standards
- Strategic focus on expanding manufacturing and marketing capabilities
Risks Involved
- Heavy dependence on revenues generated from Gujarat region, exposing it to regional market risks
- Limited number of key clients and suppliers, which could affect stability
- Absence of diversified revenue streams may impact business during sector downturns
Expert Verdict
The Medistep Healthcare Ltd IPO offers a well-structured opportunity for investors interested in India’s growing healthcare SME space. The fixed price IPO with no significant grey market premium indicates a fair valuation. Potential investors should consider the regional concentration risk while weighing the company’s robust financial growth and sector expertise. Overall, it represents a cautiously optimistic investment, suitable for those with a moderate risk appetite seeking exposure to healthcare manufacturing.
Subscription Status and Allotment
The IPO opened on August 8, 2025, and closed on August 12, 2025. The allotment is expected around August 13, 2025, followed by refunds and listing on August 18, 2025. Subscription details on QIB, NII, and Retail categories were consistent with typical SME IPO patterns, with retail investors showing strong interest due to the company’s growth story.
Allotment & Listing Timeline
- Issue Open: August 8, 2025
- Issue Close: August 12, 2025
- Allotment Finalization: August 13, 2025
- Refunds Initiation: August 14, 2025
- Listing Date: August 18, 2025
Frequently Asked Questions
- What is the price band for Medistep Healthcare Ltd IPO? The IPO is fixed priced at ₹43 per share.
- When does the IPO open and close? The IPO opens on August 8, 2025, and closes on August 12, 2025.
- What is the lot size? Lot size varies between 1500 to 3000 shares depending on application.
- Where will the shares be listed? Shares will be listed on NSE SME platform.
- How much is the issue size? Approximately ₹16.09 crore.
How to Apply for Medistep Healthcare Ltd IPO
Investors can apply for the Medistep Healthcare Ltd SME IPO through major stockbrokers like Zerodha, Upstox, and others using their online trading platforms or apps. The IPO can also be applied via the online application method through the NSE SME portal for eligible investors. For more detailed steps, visit Zerodha IPO Application Guide.
By staying updated and applying on time, investors can capitalize on this promising SME IPO opportunity in the healthcare segment.